Loading...
XSHG
600671
Market cap346mUSD
Jul 10, Last price  
19.21CNY
1D
-0.41%
1Q
-8.39%
Jan 2017
-37.65%
Name

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

Chart & Performance

D1W1MN
XSHG:600671 chart
P/E
132.75
P/S
11.11
EPS
0.14
Div Yield, %
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
0.39%
Revenues
211m
-3.06%
259,671,298265,228,863253,978,179245,336,892234,226,890277,265,339229,078,894281,468,860148,727,33894,765,832123,725,457176,382,787358,470,846297,072,373206,627,322147,069,186108,906,178121,778,535217,295,932210,656,927
Net income
18m
+15.59%
386,43015,120,9894,079,5180026,439,207-88,842,4422,108,4252,713,434-21,543,6821,217,1918,141,582-9,876,34850,680,111-40,518,317-29,801,424-67,517,053-38,275,14615,245,83117,622,617
CFO
12m
55,387,26847,532,66521,189,1807,583,47500012,372,830653,79001,606,84924,520,31970,706,116161,127,708000-20,428,820011,795,142
Dividend
Aug 24, 20050.16377 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, a company founded in 1958 and based in Hangzhou, China, operates a multifaceted business primarily focused on the pharmaceutical sector. Through its various subsidiaries, the company specializes in both the production and distribution of medicines throughout China. Its extensive product range includes the manufacturing and sale of a diverse array of pharmaceuticals and health-related goods. These encompass various dosage forms such as tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, and soft capsules, as well as a selection of health foods. Beyond finished products, Hangzhou TianMuShan is also involved in the trade of raw materials like menthol and peppermint oil. The company also offers a comprehensive selection of traditional Chinese medicine, including prepared formulas, individual herbal pieces, and fresh herbs. Furthermore, it provides specialized medical services such as custom decoction preparation and delivery, herbal slicing and powder grinding, and traditional Chinese medicine diagnosis and treatment. In addition to its core pharmaceutical activities, the enterprise has diversified into other ventures, including software development, remote health management solutions, commercial property administration, food services, and internet information businesses.
IPO date
Aug 23, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT